Howard Koch, MD
Internal Medicine · Sunrise, FLNPI 1003872375
Payments from drug & device makers
Across 464 payments — averaging $11,983 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$2.2M
- Modernatx, Inc.$1.8M
- Eli Lilly$817K
- Tolmar, Inc.$356K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$300K
- AstraZeneca$30K
- plus $57K from 22 others
Across 1 payment — averaging $51,040 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$51K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 83 | $2,174,234 |
| Modernatx, Inc. | 70 | $1,825,036 |
| Eli Lilly | 4 | $816,699 |
| Tolmar, Inc. | 28 | $356,315 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 145 | $300,200 |
| AstraZeneca | 2 | $30,479 |
| Cleerly, Inc. | 7 | $30,206 |
| Amgen | 35 | $25,153 |
| Otsuka America Pharmaceutical, Inc. | 14 | $362 |
| Gilead | 13 | $261 |
| Pfizer | 13 | $252 |
| Johnson & Johnson | 11 | $206 |
| Novartis | 7 | $132 |
| Astellas Pharma US Inc | 6 | $127 |
| Sumitomo Pharma America, Inc. | 4 | $100 |
| Neurocrine Biosciences, Inc. | 2 | $74 |
| Eisai Inc. | 4 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $57 |
| Boehringer Ingelheim | 2 | $46 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Sanofi Pasteur Inc. | 2 | $37 |
| Bayer | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
How this compares
$5,560,222 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Sunrise
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
- Michael DeverWindermere$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.